Panel Discussion | DCB for Coronary Applications

Monday, March 9, 2026

9:04 AM - 9:20 AM EST

Location: International Ballroom West

Moderator(s)

Bernardo Cortese, MD, FESC, FSCAI

Director of Coronary Program
University Hospitals
Cleveland, Ohio, United States

Disclosure information not submitted.
Ricardo A. Costa, MD, PhD

Interventional Cardiologist - Percutaneous Intervention Research Medical Section Chief
Institute Dante Pazzanese of Cardiology
Sao Paulo, Sao Paulo, Brazil

Disclosure information not submitted.
Bruno Scheller, MD

Professor of Clinical and Experimental Interventional Cardiology
University of Saarland
Homburg, Saarland, Germany

Disclosure(s): B.Braun: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); InnoRa GmbH: Owner/Co-Owner Founder/Co-Founder (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panel Discussant(s)

George Adams, MD MHS MBA FACC FSCAI

Chief Medical Officer, Cordis
Cordis, North Carolina, United States

Disclosure information not submitted.
Fernando Alfonso, MD

Head, Department of Cardiology
Hospital Univeritario La Princesa, Madrid

Disclosure(s): No financial relationships to disclose
Debabrata Dash, MD, DM, FICC, FSCAI, FAPHA, , FACC, FESC

Consultant Interventional Cardiologist
Aster Hospital, Al Mankhool Dubai, UAE
Dubai, Dubai, United Arab Emirates

Disclosure(s): No financial relationships to disclose
Aloke V. Finn, MD

President CVPath/Prof. Of Medicine University of Maryland
CVPath
Gaithersburg, Maryland, United States

Disclosure(s): Concept Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
BP

Brian Pullin, MS

Director, Division of Coronary and Peripheral Intervention Devices
FDA
Silver Spring, Maryland, United States

Disclosure information not submitted.
Ronald J. Solar, PhD, FESC

President
Renaissance Biomedical, Inc.
San Diego, California, United States

Disclosure(s): Micromedical Solutions: Stock Options [in privately held companies] (Ongoing)
Renu Virmani, MD

President
CVPath Institute, Inc.
Gaithersburg, Maryland, United States

Disclosure information not submitted.

Disclosure(s):

Bruno Scheller, MD: B.Braun: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); InnoRa GmbH: Owner/Co-Owner Founder/Co-Founder (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Fernando Alfonso, MD: No financial relationships to disclose

Debabrata Dash, MD, DM, FICC, FSCAI, FAPSC, FCCP, FACC, FESC: No financial relationships to disclose

Aloke V. Finn, MD: Concept Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Ronald J. Solar, PhD, FESC: Micromedical Solutions: Stock Options [in privately held companies] (Ongoing)